EA200501310A1 - Производные бензолсульфонамидов, способ их получения и их применение для лечения боли - Google Patents

Производные бензолсульфонамидов, способ их получения и их применение для лечения боли

Info

Publication number
EA200501310A1
EA200501310A1 EA200501310A EA200501310A EA200501310A1 EA 200501310 A1 EA200501310 A1 EA 200501310A1 EA 200501310 A EA200501310 A EA 200501310A EA 200501310 A EA200501310 A EA 200501310A EA 200501310 A1 EA200501310 A1 EA 200501310A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivatives
benzolsulfonamides
pain
treatment
production
Prior art date
Application number
EA200501310A
Other languages
English (en)
Other versions
EA008921B1 (ru
Inventor
Мартин Барт
Мишель Бонду
Пьер Доде
Кристин Массардье
Дидье Тома
Жан-Мишель Луккарини
Original Assignee
Лаборатуар Фурнье С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33133107&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200501310(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0303602A external-priority patent/FR2852958B1/fr
Priority claimed from FR0304530A external-priority patent/FR2853648B1/fr
Application filed by Лаборатуар Фурнье С.А. filed Critical Лаборатуар Фурнье С.А.
Publication of EA200501310A1 publication Critical patent/EA200501310A1/ru
Publication of EA008921B1 publication Critical patent/EA008921B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

Настоящее изобретение относится к новым производным бензолсульфонамида формулы I, значения заместителей которой приведены в описании изобретения, к способу их получения и к их применению в терапии.
EA200501310A 2003-03-25 2004-03-24 Производные бензолсульфонамидов, способ их получения и их применение для лечения боли EA008921B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0303602A FR2852958B1 (fr) 2003-03-25 2003-03-25 Nouveaux derives de benzenesulfonamides et leur utilisation en therapeutique
FR0304530A FR2853648B1 (fr) 2003-04-11 2003-04-11 Nouveaux derives de benzenesulfonamides et leur utilisation en therapeutique
PCT/FR2004/000723 WO2004087700A1 (fr) 2003-03-25 2004-03-24 Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur

Publications (2)

Publication Number Publication Date
EA200501310A1 true EA200501310A1 (ru) 2006-06-30
EA008921B1 EA008921B1 (ru) 2007-08-31

Family

ID=33133107

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501310A EA008921B1 (ru) 2003-03-25 2004-03-24 Производные бензолсульфонамидов, способ их получения и их применение для лечения боли

Country Status (20)

Country Link
US (1) US7538111B2 (ru)
EP (1) EP1606288B1 (ru)
JP (1) JP4593559B2 (ru)
AT (1) ATE432930T1 (ru)
AU (1) AU2004226197B2 (ru)
BR (1) BRPI0408689B8 (ru)
CA (1) CA2519110C (ru)
DE (1) DE602004021358D1 (ru)
DK (1) DK1606288T3 (ru)
EA (1) EA008921B1 (ru)
ES (1) ES2327338T3 (ru)
IL (1) IL170630A (ru)
MA (1) MA27629A1 (ru)
MX (1) MXPA05010288A (ru)
NO (1) NO330888B1 (ru)
PT (1) PT1606288E (ru)
SI (1) SI1606288T1 (ru)
TN (1) TNSN05238A1 (ru)
UA (1) UA83821C2 (ru)
WO (1) WO2004087700A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060217362A1 (en) * 2004-12-29 2006-09-28 Tung Jay S Novel compounds useful for bradykinin B1 receptor antagonism
DE102006039003A1 (de) * 2006-08-19 2008-02-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Verbindungen
JP5406722B2 (ja) * 2006-10-16 2014-02-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング ブラジキニン１受容体モジュレータとしての置換されたスルホンアミド誘導体
DE102007034620A1 (de) * 2007-07-25 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue B1-Antagonisten
EP2025675A1 (de) * 2007-08-14 2009-02-18 Boehringer Ingelheim International GmbH Arylsulfonamide mit analgetischer Wirkung
NZ583815A (en) * 2007-08-14 2012-03-30 Boehringer Ingelheim Int Aryl Sulfonamides with an Analgesic Action
EP2229395A1 (en) * 2008-01-17 2010-09-22 Grünenthal GmbH Substituted sulfonamide derivatives
TW200940523A (en) * 2008-03-17 2009-10-01 Gruenenthal Gmbh Substituted sulfonamide derivatives
MX2010011095A (es) 2008-04-08 2010-11-05 Gruenenthal Gmbh Derivados de sulfonamidas sustituidos.
JP2011516514A (ja) * 2008-04-08 2011-05-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 置換スルホンアミド誘導体
TWI482629B (zh) * 2008-07-01 2015-05-01 Tobishi Pharmaceutical Co 下泌尿道疾病治療劑及下泌尿道症狀改善劑
US8207335B2 (en) * 2009-02-13 2012-06-26 Boehringer Ingelheim International Gmbh Process for making certain compounds having B1 antagonistic activity
WO2023028056A1 (en) 2021-08-24 2023-03-02 Genentech, Inc. 3-amino piperidyl sodium channel inhibitors
WO2024097848A1 (en) 2022-11-03 2024-05-10 Oric Pharmaceuticals, Inc. Malonate and glycolate salts of an egfr inhibitor
WO2024096624A1 (en) * 2022-11-03 2024-05-10 Voronoi Inc. Fumarate, tartrate, malate, and citrate salts of an egfr inhibitor

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84171B (pt) 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados das n alfa-aril-sulfonilamiminoacil-p- -amidinofenil-alaninamidas, bem como dos seus derivados de sintese e das composicoes farmaceuticas que os contem
PT84170B (pt) 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
AU1354292A (en) 1991-03-18 1992-10-21 Pentapharm Ag Parasubstituted phenylalanine derivates
DE4206858A1 (de) 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2701480B1 (fr) 1993-02-15 1995-05-24 Sanofi Elf Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant.
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
FR2735128B1 (fr) 1995-06-07 1997-07-25 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique.
US5834431A (en) 1995-09-08 1998-11-10 Cortech, Inc. Des-Arg9 -BK antagonists
FR2743073B1 (fr) 1995-12-29 1998-02-20 Fournier Ind & Sante Nouveaux composes de 1-benzenesulfonylpyrrolidine, procede de preparation et utilisation en therapeutique
FR2743562B1 (fr) * 1996-01-11 1998-04-03 Sanofi Sa Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant
FR2751650B1 (fr) 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
IL128189A0 (en) * 1996-08-23 1999-11-30 Pfizer Arylsulfonylamino hydroxamic acid derivatives
GB9621814D0 (en) * 1996-10-19 1996-12-11 British Biotech Pharm Metalloproteinase inhibitors
FR2756562B1 (fr) 1996-12-04 1999-01-08 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
FR2766148B1 (fr) 1997-07-16 1999-09-17 Soc D Const De Materiel Metall Chariot comportant un dispositif de refroidissement pouvant etre mis en oeuvre a l'instant choisi par l'utilisateur et procede pour apporter un mets rechauffe
JP2003505384A (ja) 1999-07-15 2003-02-12 ファーマコピーア，インコーポレーティッド ブラジキニンｂ１受容体アンタゴニスト
SE9903930D0 (sv) 1999-10-29 1999-10-29 Astra Pharma Inc Novel compounds and a novel process for their preparation
FR2819254B1 (fr) * 2001-01-08 2003-04-18 Fournier Lab Sa Nouveaux composes de la n-(phenylsulfonyl) glycine, leur procede de preparation et leur utilisation pour obtenir des compostions pharmaceutiques
AR033879A1 (es) * 2001-05-07 2004-01-07 Smithkline Beecham Corp Compuesto sulfonamida, composicion farmaceutica que lo comprende, su uso para preparar dicha composicion y procedimiento para la obtencion de dicho compuesto
WO2002099388A2 (en) 2001-06-07 2002-12-12 Merck & Co., Inc. Benzodiazepine bradykinin antagonists

Also Published As

Publication number Publication date
AU2004226197B2 (en) 2009-12-03
JP4593559B2 (ja) 2010-12-08
EA008921B1 (ru) 2007-08-31
TNSN05238A1 (fr) 2007-06-11
MA27629A1 (fr) 2005-11-01
PT1606288E (pt) 2009-08-26
US7538111B2 (en) 2009-05-26
ATE432930T1 (de) 2009-06-15
WO2004087700A1 (fr) 2004-10-14
AU2004226197A1 (en) 2004-10-14
UA83821C2 (ru) 2008-08-26
DE602004021358D1 (de) 2009-07-16
IL170630A (en) 2012-02-29
DK1606288T3 (da) 2009-10-05
MXPA05010288A (es) 2005-11-17
BRPI0408689A (pt) 2006-03-28
WO2004087700A8 (fr) 2004-11-18
SI1606288T1 (sl) 2009-10-31
CA2519110C (fr) 2012-09-18
EP1606288A1 (fr) 2005-12-21
NO20054361L (no) 2005-11-01
NO20054361D0 (no) 2005-09-20
NO330888B1 (no) 2011-08-08
ES2327338T3 (es) 2009-10-28
JP2006521333A (ja) 2006-09-21
US20060178360A1 (en) 2006-08-10
CA2519110A1 (fr) 2004-10-14
BRPI0408689B1 (pt) 2018-09-11
BRPI0408689B8 (pt) 2021-05-25
EP1606288B1 (fr) 2009-06-03

Similar Documents

Publication Publication Date Title
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
NO20054361L (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
ATE408601T1 (de) Fredericamycin-derivate
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
SE0101387D0 (sv) Novel compounds
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
NO20054371L (no) Somatostatin-dopamin kimaere analoger
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
DE602004024037D1 (de) Substituierte heterozyklen
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
EA201070424A1 (ru) Хиназолиндионовые производные, их получение и их применения в терапии
NO20054494L (no) Peptidvektorer
EA200700637A1 (ru) Соли донепезила, подходящие для получения фармацевтических композиций
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
BR0316132A (pt) Método para estimular o crescimento de cabelo utilizando benzopiranos
EA200970122A1 (ru) Фармацевтически приемлемые солевые и полиморфные формы малеата флюпиртина
SE0002739D0 (sv) New use
TW200504051A (en) Novel acridine derivatives and their use as medicaments